Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Express Scripts

Milestone Pharmaceuticals Q1 Earnings Call Highlights

Milestone Pharmaceuticals (NASDAQ:MIST) said its first quarter of 2026 marked the beginning of commercial sales for CARDEMYST, its newly approved treatment for acute episodes of paroxysmal supraventricular tachycardia, or PSVT, while the company also moved ahead with a Phase 3 program in atrial fibr

MarketBeat

Forced to sell medications at a loss, rural Texas pharmacies seek new survival tactics

Independent rural pharmacists are starting other businesses or selling baby shower gifts to keep their stores operating. Pharmacy deserts affect 4 million Texans.

The Texas Tribune

TrumpRx is here and it helps, though a bit less than advertised

Trump's Republican Party continues to shift toward government market interventionism.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Prescription Delivery Fees Are Being Added Quietly

During the pandemic, “Free Prescription Delivery” became the standard. But as we move into 2026, the era of the $0 doorstep drop-off is quietly coming...

Saving Advice

Federal judge blocks Arkansas law barring pharmacy benefit managers from owning pharmacies in state

A federal judge has temporarily blocked an Arkansas law that would have banned pharmacy benefit managers from owning pharmacies in the state

The Independent UK

CVS and Express Scripts sue Arkansas over restriction on pharmacy benefit managers

CVS and Express Scripts are asking a federal judge to block an Arkansas law prohibiting pharmacy benefit managers from owning or operating pharmacies in the state

The Independent UK

'It's Out of Control': UnitedHealth Group and Peers Charged Americans 1000% More for Drugs

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

International Business Times UK

Read news from The Economist, FT, and more,
with one subscription

UnitedHealth, employer of slain exec Brian Thompson, found to have overcharged cancer patients for drugs by over 1,000%

The report is the latest indictment of America’s broken healthcare system.

Fortune

What are pharmacy benefit managers? A health economist explains how lack of competition drives up drug prices for everyone

Wegovy and Ozempic are weight loss drugs that promise to transform the treatment of obesity, heart disease and other chronic conditions that afflict millions of Americans. But while everyone agrees these drugs have the potential to transform lives, no one can agree on how best to pay for them.

The Conversation

Kentucky attorney general targets another big pharmacy benefit manager in opioid-related lawsuit

Kentucky’s attorney general has expanded an opioid-related lawsuit to target another pharmacy benefit manager

The Independent UK

Kentucky Attorney General Sues Express Scripts Over Opioid Crisis

Kentucky AG sues Express Scripts for alleged role in opioid crisis, highlighting oversupply of opioids and need for comprehensive strategies to combat addi...

Top News

Arkansas Sues Pharmacy Benefit Managers Over Opioid Crisis

Arkansas AG files lawsuit against pharmacy benefit managers for alleged role in opioid crisis, companies deny responsibility.

Fortune

Biden's plan to save money on Medicare drugs risks leaving shelves empty, pharmacists say

Biden is campaigning on cutting drug costs for Medicare patients, but independent pharmacists say one strategy makes it unaffordable to keep some brand-name medicines in stock.

Barchart

2 Top Dividend Stocks to Scoop Up at a Discount

These two dividend-paying stocks have underperformed in 2023, but they could be solid value picks heading into 2024.

Kiplinger

Cigna Launching Health Tracking Via Fitness Devices

Cigna, which announced earnings this month, will use the fitness data to connect participants to relevant programs.

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Drug company middlemen likely to be a focus in 118th Congress

WASHINGTON — Factions of the health care system and members of Congress are turning their fire on an oft-maligned part of the drug pricing system — the middlemen who negotiate discounts with drug companies on behalf of health plans.

Roll Call

Drug company middlemen likely to be a focus in 118th Congress - Roll Call

PBMs argue that the rebates they collect from drug companies in exchange for coverage by a health plan are used to lower premiums.

Tribune News Service

Sept. 11 health program users plagued with problems using new medical providers

A change in the companies managing health care for more than 118,000 people sickened by the Sept. 11, 2001, attacks has proven a nightmare for many enrolled in the program.

Tribune News Service

Defense Department health plan cuts its pharmacy network by nearly 15,000 outlets

Doris Spatz takes a once-a-day pill, Kisqali, to keep her metastatic breast cancer in check. As a patient in the Defense Department health system, she can fill routine prescriptions at a military pharmacy without a copay but also has the option of using a regular pharmacy through Tricare, the Defense…

Benzinga

Morgan Stanley Upgrades Cigna On Humira Prospects

Cigna Corp (NYSE: CI) is poised to benefit from the launch of bioequivalent Humira in July 2023, according to Morgan Stanley.

Tribune News Service

Federal regulators probe Cigna’s pharmacy benefit manager, CVS Caremark, and others. What are they investigating?

Express Scripts, the pharmacy benefit manager that Cigna Corp. bought in 2018, is being investigated by the Federal Trade Commission for what regulators claim is influence over drug prices wielded by pharmacy benefit managers and transparent business practices.

Benzinga

This Microcap Pharma Stock Almost Doubled Today - Read Why

UnitedHealthcare has added Kala Pharmaceuticals Inc's (NASDAQ:KALA) Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25% as a covered brand on its commercial formularies effective March 2022. Eysuvis now has coverage for approximately 118 million lives or 70% of all commercial lives. Kala also announced that Cigna Medicare had added Eysuvis as a preferred brand effective…

People

Sarah Huckabee Sanders

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.